News-Medical.Net on MSN12 天
Solascure enrols first patient in a next phase II clinical trial to advance Aurase Wound Gel
SOLASCURE Ltd (SolasCure), a biotechnology company developing a novel treatment to transform chronic wound healing, today ...
Clinical Trials Arena on MSN11 天
SolasCure initiates Phase II trial of chronic wound treatment gel
UK biotechnology company SolasCure has commenced the randomised, controlled CLEANVLU2 Phase II trial of Aurase Wound Gel for ...